Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Increased Nucleosomal DNA Fragmentation in Leukocytes of Thalassemia Patients.

Patrick B Walter, PhD, John B Porter, MD, Patricia Evans, PhD, Janet Kwiatkowski, MD, Ellis J. Neufeld, MD, PhD, Thomas D. Coates, MD, Patricia Giardina, MD, Robert jW Grady, PhD, Elliott Vichinsky, MD, Nancy F. Olivieri, MD, Felicia Trachtenberg, PhD, Daniele Alberti, MD, Ellen Fung, PhD, Bruce Ames, PhD, Annie Lui, BS, Paul Harmatz, MD

Blood (2008) 112 (11): 1868.

https://doi.org/10.1182/blood.V112.11.1868.1868

Published: 2008

Journal Articles

Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease

Claudia R. Morris, Jung H. Suh, Ward Hagar, Sandra Larkin, D. Anton Bland, Martin H. Steinberg, Elliott P. Vichinsky, Mark Shigenaga, Bruce Ames, Frans A. Kuypers, Elizabeth S. Klings

Blood (2008) 111 (1): 402–410.

https://doi.org/10.1182/blood-2007-04-081703

Published: 2008

Includes: Supplemental data

Journal Articles

Anti-Oxidant Treatment with α-Lipoic Acid and Acetyl L-Carnitine in Hemoglobinopathies.

Ashutosh Lal, MD, Jung Suh, PhD, Wafa Atamna, BA, Bridget Canty, PNP, Ward Hagar, MD, Elliott Vichinsky, MD, Frans Kuypers, PhD, Bruce Ames, PhD

Blood (2007) 110 (11): 3799.

https://doi.org/10.1182/blood.V110.11.3799.3799

Published: 2007

Journal Articles

Low Erythrocyte Glutamine-to-Glutamate Ratio: A Novel Biomarker of Hemolysis and Pulmonary Hypertension in Sickle Cell Disease.

Claudia R. Morris, MD, Jung Suh, PhD, Ward Hagar, MD, Sandra Larkin, D. Anton Bland, Martin Steinberg, MD, Elliott Vichinsky, Mark Shigenaga, PhD, Bruce Ames, PhD, Frans Kuypers, PhD, Elizabeth Klings, MD

Blood (2007) 110 (11): 2257.

https://doi.org/10.1182/blood.V110.11.2257.2257

Published: 2007

Journal Articles

Leukocyte Apoptosis and Mitochondrial Dysfunction in β-Thalassemia Patients Treated with Deferasirox or Deferoxamine.

Patrick B. Walter, PhD, John Porter, MD, Patricia Evans, PhD, Janet L. Kwiatkowski, MD, Ellis J. Neufeld, MD, Thomas Coates, MD, Patricia J. Giardina, MD, Robert W. Grady, PhD, Elliott Vichinsky, MD, Nancy F. Olivieri, MD, Felicia Trachtenberg, PhD, Daniele Alberti, MD, Jaymes Holland, PhD, Ellen Fung, PhD, Bruce Ames, PhD, Annie Lui, BS, Paul Harmatz, MD

Blood (2007) 110 (11): 2773.

https://doi.org/10.1182/blood.V110.11.2773.2773

Published: 2007

Journal Articles

Erythrocyte Glutathione Depletion Is Associated with Severity of Anemia and Pulmonary Hypertension in Patients with Sickle Cell Disease.

Claudia R. Morris, MD, Jung H. Suh, PhD, Sandra Larkin, MS, D. Anton Bland, BS, Adam Odhiambo, BS, Martin H. Steinberg, MD, Elliott P. Vichinsky, MD, Mark Shigenaga, PhD, Bruce Ames, PhD, Frans A. Kuypers, PhD, Elizabeth S. Klings, MD

Blood (2006) 108 (11): 788.

https://doi.org/10.1182/blood.V108.11.788.788

Published: 2006

Journal Articles

Control of Oxidant-Stress and Inflammation by Iron Chelators Deferasirox (ICL670) or Deferoxamine in β-Thalassemia: An Ancillary Study of the Novartis CICL670A0107 Trial.

Patrick Walter, PhD, Eric Macklin, PhD, John Porter, MD, Patricia Evans, PhD, Tom Coates, MD, Nancy F. Olivieri, MD, Patricia Giardina, MD, Janet Kwiatkowski, MD, Ellis Neufeld, MD, Bruce Ames, PhD, Jaymes Holland, Peter Marks, MD, Elliott Vichinsky, MD, Paul Harmatz, MD

Blood (2005) 106 (11): 3598.

https://doi.org/10.1182/blood.V106.11.3598.3598

Published: 2005

NARROW

Increased Nucleosomal DNA Fragmentation in Leukocytes of Thalassemia Patients.

Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease

Anti-Oxidant Treatment with α-Lipoic Acid and Acetyl L-Carnitine in Hemoglobinopathies.

Low Erythrocyte Glutamine-to-Glutamate Ratio: A Novel Biomarker of Hemolysis and Pulmonary Hypertension in Sickle Cell Disease.

Leukocyte Apoptosis and Mitochondrial Dysfunction in β-Thalassemia Patients Treated with Deferasirox or Deferoxamine.

Erythrocyte Glutathione Depletion Is Associated with Severity of Anemia and Pulmonary Hypertension in Patients with Sickle Cell Disease.

Control of Oxidant-Stress and Inflammation by Iron Chelators Deferasirox (ICL670) or Deferoxamine in β-Thalassemia: An Ancillary Study of the Novartis CICL670A0107 Trial.

Email alerts

ASH Publications

American Society of Hematology

Increased Nucleosomal DNA Fragmentation in Leukocytes of Thalassemia Patients.

Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease

Anti-Oxidant Treatment with α-Lipoic Acid and Acetyl L-Carnitine in Hemoglobinopathies.

Low Erythrocyte Glutamine-to-Glutamate Ratio: A Novel Biomarker of Hemolysis and Pulmonary Hypertension in Sickle Cell Disease.

Leukocyte Apoptosis and Mitochondrial Dysfunction in β-Thalassemia Patients Treated with Deferasirox or Deferoxamine.

Erythrocyte Glutathione Depletion Is Associated with Severity of Anemia and Pulmonary Hypertension in Patients with Sickle Cell Disease.

Control of Oxidant-Stress and Inflammation by Iron Chelators Deferasirox (ICL670) or Deferoxamine in β-Thalassemia: An Ancillary Study of the Novartis CICL670A0107 Trial.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only